Puma Biotechnology
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
Home About Us Product Pipeline News Investors Contacts Careers

About Us

Overview Management Team Board of Directors Governance

Management Team

Jeff J. Ludwig
Chief Commercial Officer

Mr. Ludwig joined Puma Biotechnology as Chief Commercial Officer in March 2020. Mr. Ludwig was Vice President Oncology Sales for Astellas Pharma Inc., a multinational pharmaceutical company based in Japan, from 2019 until 2020, where he led multiple sales teams across several oncology therapeutic products, a significant label expansion in prostate cancer and a new launch in bladder cancer. Prior to joining Astellas, Mr. Ludwig worked at Amgen Inc., a multinational biopharmaceutical company based in California, from 2001 until 2019, where he most recently held the position of Vice President Oncology Sales from 2014 to 2019. During his tenure as Vice President of Oncology Sales, he led the sales organization through numerous successful launches and contributed to a multi-billion dollar portfolio of therapeutic and supportive care products. Before assuming the Vice President of Oncology Sales role, he successfully held various other leadership positions in both oncology sales and marketing. Prior to joining Amgen, Mr. Ludwig worked in various sales and marketing roles at Eli Lilly and Company from 1988 until 2001.

Mr. Ludwig holds a B.S. in business from Arizona State University, where he graduated with honors.

Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax